MIR5696

Across TCGA pan-cancer cohorts, MIR5696 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR5696’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MIR5696 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR5696 is over-expressed in tumor, although a few such as COAD and LUSC show the opposite, repressed pattern.

COAD, LUSC, and THCA are the cancer types where MIR5696 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR5696 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−0.196	.041	1	view →
LUSC	Male	II,III,IV	−0.152	.035	1	view →
THCA	All	All	−0.117	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR5696–COAD

Open the COAD breakdown →